Proton Magnetic Resonance Spectroscopy in Kennedy Syndrome
Open Access
- 1 December 1999
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 56 (12) , 1465-1471
- https://doi.org/10.1001/archneur.56.12.1465
Abstract
KENNEDY DISEASE (KD), or X-linked spinobulbar muscular atrophy, is a motor neuronopathy caused by an expansion of a cytosine-adenine-guanine (CAG) repeat motif in the androgen receptor gene.1 The clinical picture of KD is distinctive. In their article published 30 years ago, Kennedy and coworkers2 described the typical phenotype and the X-linked recessive pattern of inheritance. Clinical signs include weakness of the limbs, mainly with proximal distribution, and bulbar symptoms with prominent weakness and fasciculation of the facial muscles and tongue. Additional symptoms are gynecomastia, postural tremor, and diabetes in some patients. The disease typically manifests in the third to fifth decade of life. Although similarities of KD and amyotrophic lateral sclerosis (ALS) do exist, there are no clinical findings suggesting upper motor neuron involvement in KD.Keywords
This publication has 10 references indexed in Scilit:
- Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophyAnnals of Neurology, 1998
- Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopyNeurology, 1998
- Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenaseHuman Molecular Genetics, 1996
- Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell typesJournal of Neuroscience, 1993
- Severity of X‐linked recessive bulbospinal neuronopathy correlates with size of the tandem cag repeat in androgen receptor geneAnnals of Neurology, 1992
- Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophyNature, 1991
- Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodiesNeuroscience, 1991
- N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC MethodJournal of Neurochemistry, 1984
- A Gas Chromatographic Method for the Determination of N‐Acetyl‐l‐Aspartic Acid, N‐Acetyl‐α‐ Aspartylglutamic Acid and β‐Citryl‐l‐Glutamic Acid and Their Distributions in the Brain and Other Organs of Various Species of AnimalsJournal of Neurochemistry, 1981
- Progressive proximal spinal and bulbar muscular atrophy of late onsetNeurology, 1968